VDB-243499 · CVE-2023-41077 · GCVE-0-2023-41077

Apple macOS up to 13.6.0 access control

CVSS Meta Temp Score CVSS is a standardized scoring system to determine possibilities of attacks. The Temp Score considers temporal factors like disclosure, exploit and countermeasures. The unique Meta Score calculates the average score of different sources to provide a normalized scoring system.	Current Exploit Price (≈) Our analysts are monitoring exploit markets and are in contact with vulnerability brokers. The range indicates the observed or calculated exploit price to be seen on exploit markets. A good indicator to understand the monetary effort required for and the popularity of an attack.	CTI Interest Score Our Cyber Threat Intelligence team is monitoring different web sites, mailing lists, exploit markets and social media networks. The CTI Interest Score identifies the interest of attackers and the security community for this specific vulnerability in real-time. A high score indicates an elevated risk to be targeted for this vulnerability.
5.3	$0-$5k	0.00

Summaryinfo

A vulnerability marked as critical has been reported in Apple macOS up to 13.6.0. This vulnerability affects unknown code. This manipulation causes access control. The identification of this vulnerability is CVE-2023-41077. The attack can only be executed locally. There is no exploit available. It is suggested to upgrade the affected component.

Detailsinfo

A vulnerability has been found in Apple macOS up to 13.6.0 (Operating System) and classified as critical. Affected by this vulnerability is an unknown code. The manipulation with an unknown input leads to a access control vulnerability. The CWE definition for the vulnerability is CWE-284. The product does not restrict or incorrectly restricts access to a resource from an unauthorized actor. As an impact it is known to affect confidentiality, integrity, and availability.

The weakness was shared 10/25/2023. It is possible to read the advisory at support.apple.com. This vulnerability is known as CVE-2023-41077 since 08/22/2023. The technical details are unknown and an exploit is not publicly available. The attack technique deployed by this issue is T1068 according to MITRE ATT&CK.

Upgrading to version 13.6.1 eliminates this vulnerability.

Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.

Productinfo

Type

Operating System

Vendor

Apple

Name

macOS

Version

License

commercial

Website

Vendor: https://www.apple.com/

CPE 2.3info

CPE 2.2info

CVSSv4info

VulDB Vector: 🔍
VulDB Reliability: 🔍

CVSSv3info

VulDB Meta Base Score: 5.4
VulDB Meta Temp Score: 5.3

VulDB Base Score: 5.3
VulDB Temp Score: 5.1
VulDB Vector: 🔍
VulDB Reliability: 🔍

NVD Base Score: 5.5
NVD Vector: 🔍

CVSSv2info

AV	AC	Au	C	I	A
💳	💳	💳	💳	💳	💳
💳	💳	💳	💳	💳	💳
💳	💳	💳	💳	💳	💳

Vector	Complexity	Authentication	Confidentiality	Integrity	Availability
Unlock	Unlock	Unlock	Unlock	Unlock	Unlock
Unlock	Unlock	Unlock	Unlock	Unlock	Unlock
Unlock	Unlock	Unlock	Unlock	Unlock	Unlock

VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍

Exploitinginfo

Class: Access control
CWE: CWE-284 / CWE-266
CAPEC: 🔍
ATT&CK: 🔍

Physical: Partially
Local: Yes
Remote: Partially

Availability: 🔍
Status: Not defined

EPSS Score: 🔍
EPSS Percentile: 🔍

Price Prediction: 🔍
Current Price Estimation: 🔍

0-Day	Unlock	Unlock	Unlock	Unlock
Today	Unlock	Unlock	Unlock	Unlock

Threat Intelligenceinfo

Interest: 🔍
Active Actors: 🔍
Active APT Groups: 🔍

Countermeasuresinfo

Recommended: Upgrade
Status: 🔍

0-Day Time: 🔍

Upgrade: macOS 13.6.1

Timelineinfo

08/22/2023 🔍
10/25/2023 +64 days 🔍
10/25/2023 +0 days 🔍
04/11/2025 +534 days 🔍

Sourcesinfo

Vendor: apple.com

Advisory: support.apple.com
Status: Confirmed

CVE: CVE-2023-41077 (🔍)
GCVE (CVE): GCVE-0-2023-41077
GCVE (VulDB): GCVE-100-243499
scip Labs: https://www.scip.ch/en/?labs.20180712

Entryinfo

Created: 10/25/2023 21:34
Updated: 04/11/2025 21:06
Changes: 10/25/2023 21:34 (40), 11/17/2023 14:41 (1), 11/17/2023 14:43 (11), 04/11/2025 21:06 (16)
Complete: 🔍
Cache ID: 216::103